Hematology Analyzer Market by Product & Service (Instruments, Reagent & Consumables, and Services), Type (Fully-Automated Hematology Analyzer and Semi-Automated Hematology Analyzer), and End User (Hospitals, Clinical Laboratories, Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030.
- ALL4676983
- 261 Pages
- September 2021
- Diagnostic and Biotech
Hematology is a branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to the blood. Hematology analyzers are used in the diagnosis and treatment of a wide range of diseases related to red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting. Hematology analyzers are used to conduct a complete blood count (CBC), which is usually the first test requested by physicians to determine a patients general health status. A complete blood count includes red blood cell (RBC), white blood cell (WBC), hemoglobin, and platelet counts, as well as hematocrit levels. Other analyses include RBC distribution width, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentrations, WBC differential count in percentage and absolute value, platelet distribution width, platelet mean volume, large platelet cell ratio, platelet criteria.
The main driving factors that drive growth of the hematology analyzer market include, increase in prevalence of blood disorders such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood. In addition, technological advancements in hematology analyzers, and growth in demand for automated hematology analyzer coupled with rising preference towards high sensitivity hematology analyzer further boost the growth of the hematology analyzer market. However, high cost of hematology analyzers owing to advanced features and automation may hamper the growth of the market. Furthermore, stringent regulatory policies for hematology analyzers are also expected to limit growth of the market. In contrast, growth opportunities in emerging economics expected to offer lucrative growth opportunities for players in the hematology analyzer market.
The global hematology analyzer market is segmented on the basis of product & service, type, end user, and region to provide a detailed assessment of the market. By product & service it is classified into instruments, reagent & consumables, and services. By type, it is segmented into fully automated hematology analyzer and semi-automated hematology analyzer. Based on end user, it is categorized into hospitals, clinical laboratories, research institutes, and others. Other segment includes blood banks, and biopharma companies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the hematology analyzer market along with the current trends and future estimations to explain the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps to understand the application and products of hematology analyzer used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Product & Service
• Instruments
• Reagents & Consumables
• Services
By Type
• Fully Automated Hematology Analyzers
• Semi-automated Hematology Analyzers
By End User
• Hospitals
• Clinical Laboratories
• Research Institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Abbott Laboratories
• Danaher Corporation (Beckman Coulter Inc.)
• Bio-Rad Laboratories
• Boule Diagnostics AB
• F Hoffmann-La Roche Ltd
• Hobira Ltd
• Nihon Kohden Corporation,
• Siemens Healthineers
• Stratec SE (Diatron MI Plc.)
• Sysmex Corporation.
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of blood disorders
3.5.1.2.Technological advancements in hematology analyzers
3.5.1.3.Growth in demand for automated hematology analyzer coupled with rising preference toward high sensitivity hematology analyzer
3.5.2.Restraints
3.5.2.1.High cost of hematology analyzers
3.5.2.2.Stringent regulatory policies for hematology analyzers
3.5.3.Opportunities
3.5.3.1.Growth opportunities in emerging economics
3.5.4.Impact analysis
3.6.COVID-19 Impact analysis on the hematology analyzer market
CHAPTER 4:HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICE
4.1.Overview
4.1.1.Market size and forecast
4.2.Instruments
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.2.1.Market size and forecast for instruments, by end user
4.2.3.Market analysis, by country
4.3.Reagents and consumables
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.2.1.Market size and forecast for reagents & consumables, by end user
4.3.3.Market analysis, by country
4.4.Services
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.2.1.Market size and forecast for services, by end user
4.4.3.Market analysis, by country
CHAPTER 5:HEMATOLOGY ANALYZER MARKET, BY TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Fully Automated Hematology Analyzer
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Semi-Automated Hematology Analyzer
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:HEMATOLOGY ANALYZER MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Clinical Laboratories
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Research Institutes
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
6.5.Others
6.5.1.Market size and forecast
6.5.2.Market analysis, by country
CHAPTER 7:HEMATOLOGY ANALYZER MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.1.1.U.S. hematology analyzer market, by product & services
7.2.2.1.2.U.S. hematology analyzer market, by type
7.2.2.1.3.U.S. hematology analyzer market, by end user
7.2.2.2.Canada
7.2.2.2.1.Canada hematology analyzer market, by product & services
7.2.2.2.2.Canada hematology analyzer market, by type
7.2.2.2.3.Canada hematology analyzer market, by end user
7.2.2.3.Mexico
7.2.2.3.1.Mexico hematology analyzer market, by product & services
7.2.2.3.2.Mexico hematology analyzer market, by type
7.2.2.3.3.Mexico hematology analyzer market, by end user
7.2.3.North America market size and forecast, by product & services
7.2.4.North America market size and forecast, by type
7.2.5.North America market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany hematology analyzer market, by product & services
7.3.2.1.2.Germany hematology analyzer market, by type
7.3.2.1.3.Germany hematology analyzer market, by end user
7.3.2.2.France
7.3.2.2.1.France hematology analyzer market, by product & services
7.3.2.2.2.France hematology analyzer market, by type
7.3.2.2.3.France hematology analyzer market, by end user
7.3.2.3.UK
7.3.2.3.1.UK hematology analyzer market, by product & services
7.3.2.3.2.UK hematology analyzer market, by type
7.3.2.3.3.UK hematology analyzer market, by end user
7.3.2.4.Italy
7.3.2.4.1.Italy hematology analyzer market, by product & services
7.3.2.4.2.Italy hematology analyzer market, by type
7.3.2.4.3.Italy hematology analyzer market, by end user
7.3.2.5.Spain
7.3.2.5.1.Spain hematology analyzer market, by product & services
7.3.2.5.2.Spain hematology analyzer market, by type
7.3.2.5.3.Spain hematology analyzer market, by end user
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe hematology analyzer market, by product & services
7.3.2.6.2.Rest of Europe hematology analyzer market, by type
7.3.2.6.3.Rest of Europe hematology analyzer market, by end user
7.3.3.Europe market size and forecast, by product & services
7.3.4.Europe market size and forecast, by type
7.3.5.Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan hematology analyzer market, by product & services
7.4.2.1.2.Japan hematology analyzer market, by type
7.4.2.1.3.Japan hematology analyzer market, by end user
7.4.2.2.China
7.4.2.2.1.China hematology analyzer market, by product & services
7.4.2.2.2.China hematology analyzer market, by type
7.4.2.2.3.China hematology analyzer market, by end user
7.4.2.3.Australia
7.4.2.3.1.Australia hematology analyzer market, by product & services
7.4.2.3.2.Australia hematology analyzer market, by type
7.4.2.3.3.Australia hematology analyzer market, by end user
7.4.2.4.India
7.4.2.4.1.India hematology analyzer market, by product & services
7.4.2.4.2.India hematology analyzer market, by type
7.4.2.4.3.India hematology analyzer market, by end user
7.4.2.5.South Korea
7.4.2.5.1.South Korea hematology analyzer market, by Product & services
7.4.2.5.2.South Korea hematology analyzer market, by type
7.4.2.5.3.South Korea hematology analyzer market, by end user
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific hematology analyzer market, by product & services
7.4.2.6.2.Rest of Asia-Pacific hematology analyzer market, by type
7.4.2.6.3.Rest of Asia-Pacific hematology analyzer market, by end user
7.4.3.Asia-Pacific market size and forecast, by product & services
7.4.4.Asia-Pacific market size and forecast, by type
7.4.5.Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil hematology analyzer market, by product & services
7.5.2.1.2.Brazil hematology analyzer market, by type
7.5.2.1.3.Brazil hematology analyzer market, by end user
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia hematology analyzer market, by product & services
7.5.2.2.2.Saudi Arabia hematology analyzer market, by type
7.5.2.2.3.Saudi Arabia hematology analyzer market, by end user
7.5.2.3.South Africa
7.5.2.3.1.South Africa hematology analyzer market, by product & services
7.5.2.3.2.South Africa hematology analyzer market, by type
7.5.2.3.3.South Africa hematology analyzer market, by end user
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA hematology analyzer market, by product & services
7.5.2.4.2.Rest of LAMEA hematology analyzer market, by type
7.5.2.4.3.Rest of LAMEA hematology analyzer market, by end user
7.5.3.LAMEA market size and forecast, by product & services
7.5.4.LAMEA market size and forecast, by type
7.5.5.LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.BIO-RAD LABORATORIES, INC.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.3.BOULE DIAGNOSTICS AB
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.DANAHER CORPORATION (BECKMAN COULTER INC.)
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.F. HOFFMANN-LA ROCHE AG
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.HORIBA, LTD.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.NIHON KOHDEN CORPORATION
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.SIEMENS AG
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.STRATEC SE (DIATRON MI PLC)
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.SYSMEX CORPORATION
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
TABLE 01.GLOBAL HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 02.HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY REGION, 2020-2030($MILLION)
TABLE 03.HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY END USER, 2020-2030($MILLION)
TABLE 04.HEMATOLOGY ANALYZER MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2020-2030($MILLION)
TABLE 05.HEMATOLOGY ANALYZER MARKET FOR REAGENTS & CONSUMABLES, BY END USER, 2020-2030($MILLION)
TABLE 06.HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY REGION, 2020-2030($MILLION)
TABLE 07.HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY END USER, 2020-2030($MILLION)
TABLE 08.GLOBAL HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 09.HEMATOLOGY ANALYZER MARKET FOR FULLY AUTOMATED HEMATOLOGY ANALYZER, BY REGION, 2020-2030($MILLION)
TABLE 10.HEMATOLOGY ANALYZER MARKET FOR SEMI-AUTOMATED HEMATOLOGY ANALYZER, BY REGION, 2020-2030($MILLION)
TABLE 11.GLOBAL HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 12.HEMATOLOGY ANALYZER MARKET FOR HOSPITALS, BY REGION, 2020-2030($MILLION)
TABLE 13.HEMATOLOGY ANALYZER MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020-2030($MILLION)
TABLE 14.HEMATOLOGY ANALYZER MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020-2030($MILLION)
TABLE 15.HEMATOLOGY ANALYZER MARKET FOR OTHERS, BY REGION, 2020-2030($MILLION)
TABLE 16.HEMATOLOGY ANALYZER MARKET, BY REGION, 2020-2030($MILLION)
TABLE 17.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 18.U.S. HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 19.U.S. HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 20.U.S. HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 21.CANADA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 22.CANADA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 23.CANADA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 24.MEXICO HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 25.MEXICO HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 26.MEXICO HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 27.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 28.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 29.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 30.EUROPE HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 31.GERMANY HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 32.GERMANY HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 33.GERMANY HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 34.FRANCE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 35.FRANCE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 36.FRANCE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 37.UK HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 38.UK HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 39.UK HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 40.ITALY HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 41.ITALY HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 42.ITALY HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 43.SPAIN HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 44.SPAIN HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 45.SPAIN HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 46.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 47.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 48.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 49.EUROPE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 50.EUROPE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 51.EUROPE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 52.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 53.JAPAN HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 54.JAPAN HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 55.JAPAN HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 56.CHINA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 57.CHINA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 58.CHINA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 59.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 60.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 61.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 62.INDIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 63.INDIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 64.INDIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 65.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 66.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 67.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 68.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 69.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 70.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 71.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 72.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 73.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 74.LAMEA HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 75.BRAZIL HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 76.BRAZIL HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 77.BRAZIL HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 78.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 79.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 80.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 81.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 82.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 83.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY END USER 2020-2030($MILLION)
TABLE 84.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 85.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 86.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, END USER, 2020-2030($MILLION)
TABLE 87.LAMEA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 88.LAMEA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 89.LAMEA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 90.ABBOTT: COMPANY SNAPSHOT
TABLE 91.ABBOTT: OPERATING SEGMENTS
TABLE 92.ABBOTT: PRODUCT PORTFOLIO
TABLE 93.ABBOTT: KEY DEVELOPMENTS
TABLE 94.BIORAD: COMPANY SNAPSHOT
TABLE 95.BIORAD: OPERATING SEGMENTS
TABLE 96.BIORAD: PRODUCT PORTFOLIO
TABLE 97.BOULE: COMPANY SNAPSHOT
TABLE 98.BOULE: OPERATING SEGMENTS
TABLE 99.BOULE: PRODUCT PORTFOLIO
TABLE 100.BOULE: KEY DEVELOPMENTS
TABLE 101.DANAHER: COMPANY SNAPSHOT
TABLE 102.DANAHER: OPERATING SEGMENTS
TABLE 103.DANAHER: PRODUCT PORTFOLIO
TABLE 104.DANAHER: KEY DEVELOPMENTS
TABLE 105.ROCHE: COMPANY SNAPSHOT
TABLE 106.ROCHE: OPEARING SEGMENTS
TABLE 107.ROCHE: PRODUCT PORTFOLIO
TABLE 108.ROCHE: KEY DEVELOPMENTS
TABLE 109.HORIBA: COMPANY SNAPSHOT
TABLE 110.HORIBA: OPERATING SEGMENTS
TABLE 111.HORIBA: PRODUCT PORTFOLIO
TABLE 112.HORIBA: KEY DEVELOPMENTS
TABLE 113.NIHON: COMPANY SNAPSHOT
TABLE 114.NIHON: OPERATING SEGMENTS
TABLE 115.NIHON: PRODUCT PORTFOLIO
TABLE 116.NIHON: KEY DEVELOPMENTS
TABLE 117.SIEMENS: COMPANY SNAPSHOT
TABLE 118.SIEMENS: OPERATING SEGMENTS
TABLE 119.SIEMENS: PRODUCT PORTFOLIO
TABLE 120.SIEMENS: KEY DEVELOPMENTS
TABLE 121.STRATEC: COMPANY SNAPSHOT
TABLE 122.STRATEC: OPERATING SEGMENTS
TABLE 123.STRATEC: PRODUCT PORTFOLIO
TABLE 124.STRATEC: KEY DEVELOPMENTS
TABLE 125.SYSMEX: COMPANY SNAPSHOT
TABLE 126.SYSMEX: OPERATING SEGMENTS
TABLE 127.SYSMEX: PRODUCT PORTFOLIO
TABLE 128.SIEMENS: KEY DEVELOPMENTS
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
